JHJM van Krieken - Concepedia

Author

JHJM van Krieken

Leiden University Medical Center

Also Known As

JHJM van Krieken, JHJM van Krieken

Publications

992

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Leiden University Radboud University Nijmegen Radboud University Medical Center

About

JHJM van Krieken is an author at Leiden University Medical Center specializing in pathology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	559
2	Pathology	6	6	559
3	Immunology	1	1	43
4	Pharmacology	1	1	40
5	Genetic Epidemiology	1	1	16

JHJM van Krieken

Publications

989

Citations

H-Index

Page 1

	Year	Citations
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma FJGM Kubben, S Ganesh, MM Heerding, British Journal of Cancer Gastrointestinal OncologyMalignant DiseaseMedicinePathologyGastric Carcinoma	1996	299
Immunohistochemical profiling based on Bcl‐2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma JJF Muris, CJLM Meijer, W Vos, The Journal of Pathology	2006	232
Signet ring cell differentiation in mucinous colorectal carcinoma ME Börger, MJEM Gosens, JWM Jeuken, The Journal of Pathology	2007	105
Superoxide dismutases in relation to the overall survival of colorectal cancer patients A. M. L. Janssen, CB Bosman, G Griffioen, British Journal of Cancer Overall SurvivalMedicinePathologyColorectal CancerSuperoxide Dismutases	1998	94
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance RAEM Tollenaar, JHJM van Krieken, H-J van Slooten, British Journal of Cancer Immunohistochemical DetectionTumor BiologyMedicinePathologyColorectal Cancer	1998	67
FISH analysis of MALT lymphoma‐specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma MI Schreuder, JJ Hoefnagel, PM Jansen, The Journal of Pathology	2005	65
CD44 expression predicts disease outcome in localized large B cell lymphoma Paul Drillenburg, VJM Wielenga, MHH Kramer, Leukemia Hematological MalignancyDisease OutcomeLymphoid NeoplasiaImmunologyPathology	1999	43
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer S Ganesh, M HEERDING, JHJM van Krieken, British Journal of Cancer Chemoprevention StrategyPlasminogen ActivatorsMedicineSurvival PrognosisPharmacology	1997	40
Selective loss of B‐cell phenotype in lymphocyte predominant Hodgkin lymphoma Sara Tedoldi, Anja Mottok, Jianming Ying, The Journal of Pathology	2007	28
Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphoma MA Hoeve, SC Ferreira Mota, Ed Schuuring, Leukemia Lymphoid NeoplasiaAllelic VariantGeneticsGenetic EpidemiologyPathology	1999	16

Page 1